Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trialResearch in context

Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trialResearch in context

Summary: Background: Smoking cessation is challenging, despite making use of established smoking cessation therapies. Preclinical studies and one clinical pilot study suggest the antidiabetic drug glucagon-like peptide-1 (GLP-1) analogue to modulate addictive behaviours and nicotine craving. Previo...

Descripció completa

Dades bibliogràfiques
Autors principals: Hualin Lüthi, Sophia Lengsfeld, Thilo Burkard, Andrea Meienberg, Nica Jeanloz, Tanja Vukajlovic, Katja Bologna, Michelle Steinmetz, Cemile Bathelt, Clara O. Sailer, Mirjam Laager, Deborah R. Vogt, Lars G. Hemkens, Benjamin Speich, Sandrine A. Urwyler, Jill Kühne, Fabienne Baur, Linda N. Lutz, Tobias E. Erlanger, Mirjam Christ-Crain, Bettina Winzeler
Format: Article
Idioma:English
Publicat: Elsevier 2024-02-01
Col·lecció:EClinicalMedicine
Matèries:
Glucagon-like peptide-1 (GLP-1) analogues
Quitting smoking
Long-term abstinence
Post-cessation weight gain
Accés en línia:http://www.sciencedirect.com/science/article/pii/S2589537024000087

Internet

http://www.sciencedirect.com/science/article/pii/S2589537024000087

Ítems similars